Delivery Order SPE2D021D0005-SPE2D324F184K
Award Date
8/7/24
Potential Completion Date
8/12/24
Potential Value
$3.3K
Federal Agency
Medical Supply Chain
Awardee
Genentech Usa, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
South San Francisco, CA 94080, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Activase 50mg injectable medication to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $81,537.62 and was awarded on November 25, 2020, with an ultimate completion date of December 23, 2020. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Genentech USA, Inc., a foreign-owned, for-profit biotechnology and pharmaceutical manufacturer. The $872,420.96 firm fixed-price contract is for the provision of various medical supplies and pharmaceuticals, including critical medications such as Tamiflu, Activase, TNKase, and Xofluza, as well as routine medications like clonazepam and diazepam tablets. The contract has an ultimate completion date of June 22,...
The Defense Logistics Agency Troop Support Medical awarded a $343,886.48 firm fixed-price delivery order contract to Genentech USA, Inc., a foreign-owned for-profit pharmaceutical manufacturer. This order is placed under an existing contract vehicle and supports the agency's requirement for pharmaceutical products. Genentech holds various indefinite delivery contracts and Federal Supply Schedule agreements with government agencies, allowing them to efficiently procure vital medicines like the...
The federal contract award is for the delivery of CATHFLO ACTIVASE 2 MG VIALS to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $2,070.45 and is a firm fixed price delivery order. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not set aside and was awarded on May 19, 2025, with a completion date of May 20, 2025. Amerisourcebergen Drug Corp holds a significant...
This federal contract award is for Activase 50mg injectable medication, awarded to the prime contractor Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $20,251.13 and is a firm fixed price delivery order with a completion date of November 20, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has established itself...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Genentech USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, for the supply of TNKase 50 mg kits. The contract has a total ceiling value of $15,627.27 and is a firm fixed price delivery order with an ultimate completion date of August 20, 2024. Genentech is a major supplier of pharmaceuticals and biologics to federal agencies, holding several key contract vehicles including a $4.9 billion...
This federal contract award is for the delivery of Activase (alteplase) 50 mg vials to the Defense Logistics Agency (DLA). The $22,886.54 firm-fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has an ultimate completion date of November 5, 2024 and was not set aside for any specific business type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, worth $17,752.22, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of ACTIVASE 50 MG VIALS, a critical medical product, and has a performance period ending on December 12, 2022. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA...
This federal contract award is for the supply of ACTIVASE 50 MG VIALS, a pharmaceutical product, to the U.S. government. The contract was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies globally. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, with a ceiling value of $2,915.07 and an ultimate completion date of May 9, 2024. This is a...
This federal contract award, with ID SPE2DB22D1052|SPE2DB24FU9AW, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $7,583.27 firm fixed-price delivery order is for the supply of ACTIVASE 100 MG VIALS, a pharmaceutical product. The contract has an ultimate completion date of May 14, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical...